Hypoglycemia: all 654 studies

Page 2 of 7. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.

• Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 DiabetesCompletedNCT04614168Not applicableResults posted
• Reducing Treatment Risk in Older Adults With DiabetesCompletedNCT04585191Not applicableResults posted
• Study to Determine the Efficacy of Real-time CGM in Preventing Hypoglycemia Among Insulin-treated Patients With DM2 on Hemodialysis, Compared to Standard of Care (POC BG)CompletedNCT04473430Not applicableResults posted
• GPR119 Agonist for Hypoglycemia in Type 1 DiabetesCompletedNCT04432090Phase 2Results posted
• Cognition in Patients With Hypoglycemia, Without DiabetesCompletedNCT04430582Results posted
• A Study of Tirzepatide in Participants With Type 2 Diabetes MellitusCompletedNCT04050553Phase 1Results posted
• IN Insulin in Type 1 Diabetes (T1D) Hypoglycemia Unawareness: Safety Only PhaseTerminatedNCT04028960Phase 2Results posted
• Insulin Tolerance Test Study in Patients With Type 1 DiabetesTerminatedNCT04026750Phase 1Results posted
• 24/7 Closed-loop in Older Subjects With Type 1 DiabetesCompletedNCT04025762Not applicableResults posted
• Reducing Hypoglycemia Fear in Parents of Young Children With Type 1 DiabetesCompletedNCT03879642Not applicableResults posted
• Exercise-Induced Hypoglycemia Prevention in Adults With Type 1 Diabetes Using an Artificial PancreasCompletedNCT03859401Not applicableResults posted
• Glucagon Ready-to-Use (RTU) for Prevention of Exercise-Induced Hypoglycemia During Aerobic Exercise in Adults With T1DCompletedNCT03841526Phase 2Results posted
• Use of a Hyperinsulinemic-hypyglycemic Clamp to Study Hypoglycemia: a Method Development StudyCompletedNCT03839511Results posted
• Assessment of the Impact of Real-Time Continuous Glucose Monitoring on People Presenting With Severe HypoglycaemiaTerminatedNCT03748433Not applicableResults posted
• G-Pen Compared to Glucagen Hypokit for Severe Hypoglycemia Rescue in Adults With Type 1 DiabetesCompletedNCT03738865Phase 3Results posted
• Mechanisms for Restoration of Hypoglycemia AwarenessCompletedNCT03738852Early Phase 1Results posted
• Trial to Confirm the Clinical Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Subjects With T1DMCompletedNCT03688711Phase 3Results posted
• The VRIF Trial: Hypoglycemia Reduction With Automated-Insulin Delivery SystemCompletedNCT03674281Not applicableResults posted
• Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM ChildrenCompletedNCT03667053Phase 3Results posted
• Novel Approach for the Prevention of Hypoglycemia Associated Autonomic Failure (HAAF)TerminatedNCT03608163Phase 4Results posted
• Amitriptyline in Treating HypoglycemiaTerminatedNCT03591458Phase 2Results posted
• A Cognitive Behavioral Therapy (CBT) Intervention to Reduce Fear of Hypoglycemia in Type 1 DiabetesCompletedNCT03549104Not applicableResults posted
• Carvedilol in Treating Hypoglycemia UnawarenessTerminatedNCT03538015Phase 2Results posted
• Glucagon Infusion in T1D Patients With Recurrent Severe Hypoglycemia: Effects on Counter-Regulatory ResponsesTerminatedNCT03490942Phase 2Results posted
• Impact of Hypoglycaemia in Patients With Diabetes Mellitus Type 2 on Platelet ActivationCompletedNCT03460899Not applicableResults posted
• G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 DiabetesCompletedNCT03439072Phase 3Results posted
• Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic PatientsCompletedNCT03406897Phase 1/2Results posted
• A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes SubjectsCompletedNCT03378635Phase 3Results posted
• Safety and Efficacy of Exendin 9-39 in Patients With Postbariatric HypoglycemiaCompletedNCT03373435Phase 2Results posted
• Sitagliptin and the Risk for Hypoglycaemia in Type 2 Diabetes PatientsCompletedNCT03359590Phase 2Results posted
• Continuous Glucose Monitoring to Reduce Hypoglycemia and Improve Safety After Gastric SurgeryCompletedNCT03353415Not applicableResults posted
• A Study of Nasal Glucagon in Participants With Type 1 Diabetes MellitusCompletedNCT03339453Phase 1Results posted
• Closed-Loop Glucagon Pump for Treatment of Post-Bariatric HypoglycemiaCompletedNCT03255629Phase 1/2Results posted
• Efficacy of Glucagon In the Prevention of Hypoglycemia During Mild ExerciseTerminatedNCT03217175Not applicableResults posted
• A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes MellitusCompletedNCT03216226Phase 3Results posted
• Hybrid Closed Loop Insulin Delivery System in HypoglycemiaCompletedNCT03215914Not applicableResults posted
• A Cognitive Behavioral Intervention to Reduce Fear of Hypoglycemia in Young Adults With Type 1 DiabetesCompletedNCT03165786Not applicableResults posted
• A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia UnawarenessCompletedNCT03163511Phase 1/2Results posted
• Propranolol in Treating Hypoglycemia UnawarenessTerminatedNCT03161964Phase 2Results posted
• Naloxone, Hypoglycemia and ExerciseCompletedNCT03149770Phase 2Results posted
• Adrenergic System in Islet TransplantationCompletedNCT03079921Early Phase 1Results posted
• Euglycemia After Antenatal Late Preterm Steroids, the E-ALPS StudyCompletedNCT03076775Not applicableResults posted
• Detecting Neonatal Hypoglycemia Using Real-Time Continuous Glucose Monitoring (CGM)CompletedNCT03032523Not applicableResults posted
• Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous Glucose DataCompletedNCT03028220Not applicableResults posted
• Effects of Mild Hypoglycaemia on Cognitive Function in Type 2 DiabetesCompletedNCT03014011Not applicableResults posted
• Post Bariatric Closed Loop Glucagon TrialCompletedNCT02966275Not applicableResults posted
• CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital HyperinsulinismCompletedNCT02937558Phase 2Results posted
• Evaluation of the Hypoglycaemia Notification Device Hyposafe H02TerminatedNCT02925676Not applicableResults posted
• Efficacy, Tolerability and Pharmacokinetics of Subcutaneous Exendin (9-39) in Patients With Post Bariatric HypoglycemiaCompletedNCT02771574Phase 2Results posted
• Delivery of G-Pump™ (Glucagon Infusion) From an OmniPod® to Prevent Hypoglycemia in Post-Bariatric Surgery PatientsCompletedNCT02733588Phase 2Results posted
• Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young AdolescentsCompletedNCT02714972Not applicableResults posted
• Intra-nasal Naloxone for Treatment of Impaired Awareness of HypoglycemiaTerminatedNCT02700048Phase 1/2Results posted
• Testing Glial Pathways to HAAF in Human Subjects Using Carbon 13 Magnetic Resonance SpectroscopyCompletedNCT02690168Results posted
• The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 DiabetesCompletedNCT02660242Phase 2Results posted
• Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 DiabeticsCompletedNCT02656069Phase 3Results posted
• Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive AlgorithmsCompletedNCT02438189Not applicableResults posted
• G-Pen™ for Hypoglycemia Rescue in T1D PatientsCompletedNCT02423980Phase 2Results posted
• Mini-Dose Glucagon to Treat Non-Severe HypoglycemiaCompletedNCT02411578Phase 2Results posted
• Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and AdolescentsCompletedNCT02402933Phase 3Results posted
• Evaluation of Hypo-Safe Hypoglycaemia Alarm Device - the Pilot 2 Study - Healthy SubjectsCompletedNCT02402153Not applicableResults posted
• Risk of Nocturnal Hypoglycemia and Arrhythmias With Sitagliptin Versus Glimepiride in Patients With Type 2 DiabetesTerminatedNCT02373865Phase 4Results posted
• The Effect of Glucomannan Soluble Fiber on Glucose Homeostasis in Patients With Roux En Y (RNY) Gastric Bypass SurgeryCompletedNCT02336438Phase 4Results posted
• USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1DCompletedNCT02302963Not applicableResults posted
• Efficacy of Continuous Glucose Monitoring in Neonates With HypoglycemiaTerminatedNCT02300285Not applicableResults posted
• Adjusting Insulin Delivery to ActivityCompletedNCT02299479Not applicableResults posted
• QT Interval Abnormalities in Sulfonylurea Treated Type 2 Diabetes: Relationship to Treatment Induced HypoglycaemiaCompletedNCT02298803Not applicableResults posted
• An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT)CompletedNCT02232698Not applicableResults posted
• Allogeneic Islet Cells Transplanted Onto the OmentumCompletedNCT02213003Phase 1/2Results posted
• A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 DiabetesCompletedNCT02206152Phase 1/2Results posted
• Closed-Loop Glucagon Administration For Hypoglycemia TreatmentCompletedNCT02181127Not applicableResults posted
• Clinical Usability of Intranasal Glucagon in Treatment of HypoglycemiaCompletedNCT02171130Phase 3Results posted
• Safety and Efficacy Study of Mini-Dose Glucagon (G-Pen Mini) in Patients With Type 1 DiabetesCompletedNCT02081014Phase 2Results posted
• PK/PD Study With G-Pump (Glucagon Infusion) in T1DM PatientsCompletedNCT02081001Phase 2Results posted
• Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise ProtocolCompletedNCT02047643Not applicableResults posted
• Glycemic Excursions in Type 2 Diabetic Patients With Vildagliptin and Metformin Versus Vildagliptin and GlimepirideCompletedNCT02007278Phase 4Results posted
• Efficacy and Safety of Nasal Glucagon for Treatment of Hypoglycemia in AdultsCompletedNCT01994746Phase 3Results posted
• Hypoglycemia (Low Blood Sugar) and the HeartCompletedNCT01980914Not applicableResults posted
• Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of G-Pen(TM) (Glucagon Injection) to Treat Severe HypoglycemiaCompletedNCT01972152Phase 2Results posted
• A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic PatientsCompletedNCT01897688Phase 3Results posted
• Pramlintide (Symlin) for the Treatment of Hypoglycemia Following Gastric Bypass SurgeryCompletedNCT01841359Phase 4Results posted
• Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in ChildrenCompletedNCT01823341Phase 2Results posted
• Hypoglycemia and Autonomic Nervous System FunctionCompletedNCT01816893Not applicableResults posted
• Effects of Glimepiride on Recovery From Hypoglycemia in Participants With Type 2 Diabetes Mellitus (MK-0000-253)CompletedNCT01614769Phase 1Results posted
• Safety and Efficacy of a Novel Glucagon Formulation in Type 1 Diabetic Patients Following Insulin-induced HypoglycemiaCompletedNCT01556594Phase 2Results posted
• Glucose Counterregulation in Long Standing Type 1 DiabetesCompletedNCT01474889Not applicableResults posted
• Phase II Safety and Efficacy Study of 18FDOPA PET-CT in Children With Hyperinsulinemic HypoglycemiaCompletedNCT01468454Phase 2Results posted
• Effect of Naltrexone on Counterregulatory Mechanisms in HypoglycemiaCompletedNCT01462227Not applicableResults posted
• Maternal Lifestyle and Neonatal HypoglycemiaCompletedNCT01409382Not applicableResults posted
• Hypoglycemia and the Mineralocorticoid ReceptorCompletedNCT01394627Not applicableResults posted
• Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range SystemCompletedNCT01390259Not applicableResults posted
• Dipeptidyl Peptidase-4 Inhibitors and Alpha-cell RecoveryCompletedNCT01272583Not applicableResults posted
• Tight Glycaemic Control During Cardiac SurgeryTerminatedNCT01225159Not applicableResults posted
• Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.CompletedNCT01194479Not applicableResults posted
• Role of Glucagon-Like Peptide-1 in Postprandial HypoglycemiaCompletedNCT01162499Not applicableResults posted
• Naltrexone and Hypoglycemia in Type 1 DiabetesCompletedNCT01053078Phase 1/2Results posted
• Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose ChallengeCompletedNCT00998374Results posted
• Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal HypoglycemiaCompletedNCT00974051Not applicableResults posted
• The OBSTACLE Hypoglycemia Study (MK-0000-158)CompletedNCT00907881Results posted
• Intravenous Exenatide (Byetta) During SurgeryCompletedNCT00882050Phase 1/2Results posted
• Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 DiabetesTerminatedNCT00869414Not applicableResults posted

← Hypoglycemia overview